Publications
Information about journal articles, updated at 26-06-2022, from platform CIÊNCIAVITAE.
Integrative Profiling of Amyotrophic Lateral Sclerosis Lymphoblasts Identifies Unique Metabolic and Mitochondrial Disease Fingerprints
Cunha-Oliveira T; Carvalho M; Sardão V; Ferreiro E; Mena D; Pereira FB; Borges F; Oliveira PJ; Silva FSG, Translational Neurodegeneration. 2022. submitted Translational Neurodegeneration
Riluzole-rasagiline hybrids as multi-target-directed ligands against amyotrophic lateral sclerosis
Albertini C; Salerno A; Atzeni S; Uliassi E; Massenzio F; Maruca A; Rocca R; et al, European Journal of Medicinal Chemistry. 2022. submitted European Journal of Medicinal Chemistry
Off-target effects of etomoxir on mitochondrial complex I (In preparation)
Silva FSG; Komlódi T ; Duarte AI; Mena D; Garcia-Souza LF; Makrecka-Kuka M; Bento GJF; et al, 2022.
Liraglutide Protects Against Brain Amyloid-ß1-42 Accumulation in Female Mice with Early Alzheimer´s Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation.
Ana I. Duarte; Emanuel Candeias; Inês N. Alves; Débora Mena; Daniela F. Silva; Nuno J. Machado; Elisa J. Campos; et al, International Journal of Molecular Sciences. 5. 21. 2020. http://dx.doi.org/10.3390/ijms21051746 . 10.3390/ijms21051746 . International Journal of Molecular Sciences
All projects
Information of exclusive responsibility of the researcher 26-06-2022 , from platform CIÊNCIAVITAE.
2021/08/01 - 2021/12/31
Development of new mitochondria-targeted antioxidants to ameliorate the phenotype of the familial SOD1 amyotrophic lateral sclerosis (MITO4ALS)
PTDC/MED-FAR/29391/2017
Research Technician Fellow
Center for Neuroscience and Cell Biology (CNC); Faculty of Sciences, University of Porto, Portugal.
Funders: FCT - Fundação para a Ciência e Tecnologia
2020/09 - 2021/06
Novel mitochondria-targeted antioxidants and oxidative damage in fibroblasts (SKINSHIELD)
POCI-01-0145-FEDER- 028607
Other
Center for Neuroscience and Cell Biology (CNC); Faculty of Sciences, University of Porto, Portugal.
Funders: FCT - Fundação para a Ciência e Tecnologia
2020/09 - 2021/07
Development of new mitochondria-targeted antioxidants to ameliorate the phenotype of the familial SOD1 amyotrophic lateral sclerosis (MITO4ALS)
PTDC/MED-FAR/29391/2017
Other
Center for Neuroscience and Cell Biology (CNC); Faculty of Sciences, University of Porto, Portugal.
Funders: FCT - Fundação para a Ciência e Tecnologia
2019/11 - 2020/08
Strategic Project: Healthy Aging 2020
CENTRO-01-0145- FEDER-000012
Other
Center for Neuroscience and Cell Biology (CNC); University of Coimbra
2019/03 - 2019/12
Targeting huntingtin proteostasis and mitochondria to prevent neuronal dysfunction in Huntington´s disease
grant.Provided by PTCRIS: 139010
Other
Funders: FCT - Fundação para a Ciência e Tecnologia
2018/09 - 2019/09
Brain protection by Evolocumab in individuals at high risk for cardiovascular disease: from bench to bedside
PEPITA
Other
University of Coimbra, Faculty of Medicine
Funders: Banco Santander Totta
5 6 out of 6 projects
We use cookies to improve your visit to our website.